Galderma Group AG
GALD
Rang in Aktien
#457
Galderma Group AG operates as a dermatology company worldwide. The company... Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, NEMLUVIO, Relfydess, Benzac, and Loceryl in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.
Aktienkurs
$224.81
Marktkapitalisierung
$52.42B
Veränderung (1 Tag)
6.31%
Veränderung (1 Jahr)
31.28%
Land
CH
Handel Galderma Group AG (GALD)
Kategorie
Healthcare
Dividendenrendite-Verlauf für Galderma Group AG (GALD)
Dividendenrendite (TTM) von Galderma Group AG (Aktienkürzel: GALD) zum 2024-12-31: 0.00%
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.02%
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.02%
Dividendenrendite-Verlauf für Galderma Group AG (GALD) von 2021 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
| Jahr | Dividendenrendite | ändert |
|---|---|---|
| 2026 (TTM) | 0.19% | 137.50% |
| 2025 | 0.08% | 0.00% |
| 2024 | 0.00% | 0.00% |
| 2023 | 0.00% | 0.00% |
| 2022 | 0.00% | 0.00% |
| 2021 | 0.00% | 0.00% |
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber
| Unternehmen | Dividendenrendite | Land |
|---|---|---|
| 1.63% |
DE
|
|
| 1.50% |
DE
|
|
| 3.18% |
JP
|
|
| 0.91% |
IN
|
|
| 0.43% |
CN
|
